Health and Wealth: The Investors’ Guide to Antimicrobial Resistance (AMR), A Growing Global Health Crisis
The MSCI Sustainability Institute, IAAMR, and FAIRR have developed an Investor’s Guide to Antimicrobial Resistance (AMR), highlighting its systemic risk and its impact on sectors like healthcare, pharmaceuticals, and animal agriculture. The guide provides an overview of current research and development pipelines for novel antimicrobials and offers opportunities for strategic investments. It also provides case studies from active investors demonstrating their actions on AMR. The guide aims to provide investors with key questions to consider when adopting an “AMR lens” and offers insights into the current research and funding landscapes.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!